Delivery Order SPE2DB22D2211-SPE2DB25FSASX
- Not listed
- The Defense Logistics Agency awarded a $2,646.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 18 mg on August 11, 2025, with completion expected by August 12, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,309.13 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 31, 2025, with performance to take place at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,653.30 for Methylphenidate ER 27 mg tablets (100-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting federal medical operations. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $1,296.30 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of July 1, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.94 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This competitive, non-set-aside award represents a firm fixed-price delivery order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a firm fixed price ceiling value of $1,810.72. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,288.66 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Methylphenidate ER 27 mg tablets in quantities of 100. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under an open competition process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSASXDelivery Order
The Defense Logistics Agency awarded a $1,116.64 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 27 mg, with an ultimate completion date of July 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract was issued on July 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, covering a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The firm's demonstrated capability to meet federal procurement requirements through open competition, combined with its strategic position as a prime vendor under DLA's Troop Support Medical contract, positions it as a key supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/14/25 |